Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degenerations.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00509548
What this trial is testing

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
TargeGen 7
Not applicableUnknownNCT05569226
What this trial is testing

OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
OKKO Health 50
Not applicableStudy completedNCT07255885
What this trial is testing

CRYSTALSIGHT: ''Cohort 1.5" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop Remote Monitoring of Maculopathy at Home Using Artificial Intelligence for Eye Tracking

Who this might be right for
MaculopathyMaculopathy, Age RelatedMacular Degeneration, Age-Related+3 more
Tan Tock Seng Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT03630952
What this trial is testing

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 1,157
Not applicableActive Not RecruitingNCT06680817
What this trial is testing

A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 850
Large-scale testing (Phase 3)Looking for participantsNCT06165068
What this trial is testing

Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study

Who this might be right for
Dry Age-related Macular Degeneration
Navamindradhiraj University 174
Not applicableStudy completedNCT05091476
What this trial is testing

OcuDyne System in the Treatment of AMD

Who this might be right for
Age-Related Macular Degeneration
OcuDyne, Inc. 17
Not applicableStudy completedNCT05677685
What this trial is testing

VISUPRIME® Eye Drops

Who this might be right for
Macular Degeneration, Age RelatedMyopic Choroidal NeovascularisationProliferative Diabetic Retinopathy+2 more
VISUfarma SpA 78
Early research (Phase 1)Study completedNCT01301443
What this trial is testing

Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration
Oxford BioMedica 21
Testing effectiveness (Phase 2)UnknownNCT00745511
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Ora Bio Ltd. 96
Not applicableNot Yet RecruitingNCT06817915
What this trial is testing

This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Johannes Schiefelbein 100
Large-scale testing (Phase 3)Study completedNCT04864834
What this trial is testing

Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Sandoz 485
Testing effectiveness (Phase 2)Study completedNCT06176963
What this trial is testing

Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

Who this might be right for
Neovascular Age-related Macular DegenerationMacular EdemaRetinal Vein Occlusion
Samsung Bioepis Co., Ltd. 34
Not applicableStudy completedNCT04084587
What this trial is testing

Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Macular Degeneration AdvancedMacular Degeneration, SenileMacular Degeneration, Dry+2 more
University of Modena and Reggio Emilia 24
Not applicableStudy completedNCT03092492
What this trial is testing

AMD Ryan Initiative Study (ARIS)

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 26
Not applicableUnknownNCT02328209
What this trial is testing

Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Mie University 50
Not applicableStudy completedNCT02255981
What this trial is testing

Efficacy of Acupuncture in Macular Diseases

Who this might be right for
Age-related Macular DegenerationStargardt DiseaseMacular Dystrophy
Escuela Neijing 33
Large-scale testing (Phase 3)Study completedNCT01170767
What this trial is testing

French Evaluation Group Avastin Versus Lucentis

Who this might be right for
Age Related Macular Degeneration
Hospices Civils de Lyon 501
Large-scale testing (Phase 3)Study completedNCT03677934
What this trial is testing

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Hoffmann-La Roche 415
Large-scale testing (Phase 3)Study completedNCT04597632
What this trial is testing

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 248
Next Page